Natera Inc (NTRA) reports a 35% revenue increase and raises 2025 guidance amid strategic product expansions and operational improvements.

Discover key Q3 2025 earnings insights for Natera (NTRA): record revenue growth, improved margins, and upgraded guidance.

Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q3 CY2025 results topping the market’s revenue ...

Third quarter performance driven by strong portfolio royalty revenue growth of 47%2025 full year revenue guidance increased to $225 million - ...

Operator: Ladies and gentlemen, thank you for standing by. Hello. My name is Dustin, and I will be your conference operator ...

State-of-the-art single-cell RNA sequencing and proteomics approaches were employed to benchmark porcine and human pancreatic ...

Total GAAP operating expenses of $115.3 million for the third quarter 2025 increased by 8% as compared to $106.6 million for the third quarter 2024. Total non-GAAP operating expenses 2 were up 15% to ...

Medical malpractice cases continue to challenge healthcare systems and legal professionals alike. Parambil's template provides a systematic approach to investigating claims, identifying liable parties ...

In the field of paediatrics, the concept of normal (ie, typical)—in contrast to different, special, deviant, delayed, or ...